Skip to main content
Mark Donowitz, MD, Gastroenterology, Baltimore, MD

MarkDonowitzMD

Gastroenterology Baltimore, MD

Malabsorption

Professor of Medicine, Johns Hopkins University School of Medicine; Director, Hopkins NIH/NIDDK Conte Core Center, GI Division, Director of Basic Research

Dr. Donowitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Donowitz's full profile

Already have an account?

  • Office

    600 N Wolfe St
    Baltimore, MD 21287
    Phone+1 410-955-4166
    Fax+1 410-955-9677

Education & Training

  • Jacobi Medical Center/Albert Einstein College of Medicine
    Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1970 - 1971
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1968 - 1970
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1968

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1969 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
  • Lecturer Horace Davenport Lecturer, 2007
  • Fellow (AGAF) American Gastroenterological Association, 2006
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • COVID Diarrhea May Predict More Severe Disease
    COVID Diarrhea May Predict More Severe DiseaseAugust 22nd, 2024
  • Organoids Provide Multiple New Insights into COVID-19
    Organoids Provide Multiple New Insights into COVID-19August 16th, 2024
  • Original Article Intestinal Stem Cell-Derived Enteroids from Morbidly Obese Patients Preserve Obesity-Related Phenotypes: Elevated Glucose Absorption and Gluconeogenesis
    Original Article Intestinal Stem Cell-Derived Enteroids from Morbidly Obese Patients Preserve Obesity-Related Phenotypes: Elevated Glucose Absorption and GluconeogenesisNovember 25th, 2020
  • Join now to see all

Professional Memberships